TL13-112

• Description:

  TL13-112 is a novel Anaplastic Lymphoma Kinase (ALK) -PROTAC developed through conjugation of LDK378 and the cereblon ligand pomalidomide.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  1002.582

• Molecular Formula:

  C49H60ClN9O10S

• Notes:

  Research use only, not for human use.

• Receptor:

  PROTAC

• CAS Number:

  2229037-19-6